Randomized clinical trial, double-blind, controlled, naturalistic, multicenter and prospective, enrolling 316 patients with severe depressive disorder:
Currently it is the largest randomized clinical trial (RCT), using a pharmacogenetic test in patients
Intended to evaluate the effectiveness of Neurofarmagen in the choice of pharmacological treatment, with improvement measured by the Patient Global Impression of Improvement (PGI-I) scale within 12 weeks.
We inform you that we use first- and third-party cookies in order to improve the performance of the page and for analytical and advertising purposes. If you want more information or would like to manage them, please go to the
Cookie Settings.
I ACCEPT COOKIES
WE CARE ABOUT YOUR PRIVACY
You can set your consent preferences and determine how you want your data to be used according to the purposes detailed below.
Uncheck all
ACCEPT ALL
These cookies are necessary for the basic operation of the website and, therefore, are always active. They include cookies that remember the actions you make when browsing the website in a single session or, if requested, from session to session. They help in online shopping processes, in addition to providing assistance in security matters and in compliance with regulations.
Analytical cookies allow us to improve the web browsing experience and to provide the administrator with statistical information such as the number of visitors or how users use our platform.
They allow the effective management of advertising space on our website, tailoring advertising content to the content of the requested service or to your use of our website, which are carefully handled either by us or by third-parties. It allows us to find out your browsing habits on the Internet and show advertising related to your browsing profile.
Remember that you can always change your preferences by going to our Cookies Policy
SAVE PREFERENCES
×ATENCIÓ: Cookies no configurades en l'idioma actual. Revisa la teva configuració al plugin, gràcies!
